Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PACTR202310626983365Phase 4Recruiting
Phase 4, open-label trial of propofol (2 arms), sponsored by National Liver Institute. Primary endpoint: SedLine reading and level of sedation. Started Jul 2023; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on PACTR202310626983365.